Jointown Pharmaceutical Group Co., Ltd. Class ASSE: 600998

Announcement on the Subsidiary Receiving the "Acceptance Notice" from the National Medical Products Administration for the Market Application of Betahistine Hydrochloride Tablets

· Issued by Jointown Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on the Subsidiary Receiving the "Acceptance Notice" from the National Medical Products Administration for the Market Application of Betahistine Hydrochloride Tablets

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis